Optomed Oyj Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Juho Himberg
Chief executive officer
€64.0k
Total compensation
| CEO salary percentage | 81.3% |
| CEO tenure | 1.3yrs |
| CEO ownership | n/a |
| Management average tenure | 6.1yrs |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?
Sep 27
Earnings Update: Here's Why Analysts Just Lifted Their Optomed Oyj (HEL:OPTOMED) Price Target To €6.63
May 11Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 26% Share Price Boost
May 10Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 25% Share Price Boost
Mar 22Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts
Feb 18Market Cool On Optomed Oyj's (HEL:OPTOMED) Revenues
Dec 21Is Optomed Oyj (HEL:OPTOMED) Using Debt In A Risky Way?
Nov 15Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts
Aug 09Investors Continue Waiting On Sidelines For Optomed Oyj (HEL:OPTOMED)
Jun 01Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?
Oct 27Is Optomed Oyj (HEL:OPTOMED) A Risky Investment?
Apr 23CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -€6m |
| Jun 30 2024 | n/a | n/a | -€5m |
| Mar 31 2024 | n/a | n/a | -€4m |
| Dec 31 2023 | €64k | €52k | -€4m |
Compensation vs Market: Juho's total compensation ($USD66.34K) is below average for companies of similar size in the Finnish market ($USD327.46K).
Compensation vs Earnings: Insufficient data to compare Juho's compensation with company performance.
CEO
Juho Himberg (54 yo)
1.3yrs
Tenure
€64,000
Compensation
Mr. Juho Himberg is Chief Executive Officer of Optomed Oyj since October 1, 2023. He has served as the CEO of Aidian (former Orion Diagnostica), a leading point-of-care diagnostics company with innovative...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 1.3yrs | €64.00k | no data | |
| Founder | 21.1yrs | €156.00k | no data | |
| CFO, Chief Legal Officer & Secretary of the Board | 6.1yrs | no data | no data |
6.1yrs
Average Tenure
46yo
Average Age
Experienced Management: OPTOMED's management team is seasoned and experienced (6.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 6.1yrs | €19.00k | 0.062% € 53.8k | |
| Independent Director | 6.1yrs | €19.00k | 0.078% € 67.3k | |
| Independent Director | 1.8yrs | €19.00k | 0.017% € 15.0k | |
| Chairman of the Board | 19.1yrs | €114.00k | 0.082% € 71.3k | |
| Independent Director | 1.8yrs | €19.00k | 0.017% € 15.0k | |
| Independent Director | 4.7yrs | €19.00k | 0.037% € 31.7k | |
| Member of International Scientific Advisory Board | 4.1yrs | no data | no data | |
| Member of International Scientific Advisory Board | 4.1yrs | no data | no data | |
| Member of International Scientific Advisory Board | 4.1yrs | no data | no data | |
| Member of International Scientific Advisory Board | 4.1yrs | no data | no data | |
| Member of International Scientific Advisory Board | 4.1yrs | no data | no data |
4.1yrs
Average Tenure
65yo
Average Age
Experienced Board: OPTOMED's board of directors are considered experienced (4.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/01 23:28 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Optomed Oyj is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
| Juha Kinnunen | Inderes Oy |
| Gergana Almquist | Redeye |